retatrutide trial results news today ⭐️topline from TRIUMPH-1, a Phase 3 clinical evaluating #retatrutide, an investigational GIP / GLP-1 / glucagon triple hormone receptor agonist, in adults with obesity or “overweight” Retatrutide for Weight Loss: What

The result can include reduced appetite and what many people describe as quieter "food noise" (that constant background thinking about food), longer-lasting fullness after eating, and better blood sugar regulation

I had taken all those steroids, I was on all this stuff, and one of the things that helped me drop the weight was the Mounjaro

Because intense pharma competition weight loss drugs combined with policy pressure is forcing manufacturers to prioritize patient volume over a high list price

We may be looking at a drug class that turns out to treat obesity the same way statins treat cholesterol, not as a crutch, but as a legitimate biological correction for a system running out of spec in a modern food environment designed to overwhelm it

Managing Side Effects Some patients may experience side effects such as nausea or gastrointestinal discomfort, especially when first starting semaglutide GLP-1